On ECHEMI
Home > Drugs > Vasculitis
Vasculitis
Thrombophlebitis, also known as phlebitis, refers to inflammation of the veins. Depending on the location of the lesion, phlebitis can be divided into superficial phlebitis and deep phlebitis. Its pathological changes include hyperplasia of the vascular intima, narrowing of the lumen, and slow blood flow. The surrounding skin may present with congested erythema, sometimes accompanied by edema. It gradually subsides, and the congestion is replaced by pigmentation, and the erythema turns brown. A small number of patients may experience reactions, such as chills, fever, and increased white blood cells. Patients often complain of pain and swelling.
  • Site of disease:

    Blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Red cords, wandering superficial veins Superficial veins have a red, low-temperature cord-like object Local veins are hard cord-like Subcutaneous veins are reticularly dilated Capillary dilation
Related Drugs
Ligustrazine Hydrochloride Sodium Chloride Injection
Indication: Used to treat ischemic cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary atherosclerotic heart disease, vasculitis, etc.
Manufacturer:

Sichuan Sunnyhope Pharmaceutical Co., Ltd.

Ligustrazine Hydrochloride Sodium Chloride Injection
Indication: Used to treat ischemic cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary atherosclerotic heart disease, vasculitis, etc.
Manufacturer:

Shandong Qidu Pharmaceutical Co., Ltd.

Vascular Fukang Tablets
Manufacturer:

Shanxi Renyuantang Pharmaceutical Co., Ltd.

Tongsaimai dispersible tablets
Manufacturer:

Jiangsu Kangyuan Sunshine Pharmaceutical Co., Ltd.

Mailuoning oral liquid
Manufacturer:

Jinling Pharmaceutical Co., Ltd. Nanjing Jinling Pharmaceutical Factory

Ligustrazine Hydrochloride and Glucose Injection
Indication: Used for occlusive cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease, vasculitis, etc.
Ligustrazine Hydrochloride and Glucose Injection
Indication: Used for occlusive cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease, vasculitis, etc.
Manufacturer:

Anhui Double-Crane Pharmaceutical Co., Ltd.

Ligustrazine Hydrochloride and Glucose Injection
Indication: Used for occlusive cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease, vasculitis, etc.
Ligustrazine Hydrochloride and Glucose Injection
Indication: Used for occlusive cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease, vasculitis, etc.
Manufacturer:

Lunan BETTER Pharmaceutical Co., Ltd.

Safflower injection
Manufacturer:

Shanxi Kangyi Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.